Key Objective
Initial public offering of 19,375,070 equity shares of face value of Rs. 10 each ("Equity Shares") of Emcure Pharmaceuticals Limited (The "Company") for cash at a price of Rs. 1,008^ per equity share (including a share premium of Rs. 998 per equity share) (the "Offer Price") aggregating to Rs. 1952.03^ crores (the "Offer") comprising a fresh issue of 7,946,231 equity shares of face value of Rs. 10 each aggregating to Rs. 800.00^ crores by the company (the "Fresh Issue") and an offer for sale of 11,428,839 equity shares of face value of Rs. 10 each aggregating to Rs. 1152.03 crores including 420,000 equity shares of face value of Rs. 10 each aggregating to Rs. 42.34 crores by Satish Ramanlal Mehta, 1,268,600 equity shares of face value of Rs. 10 each aggregating to Rs. 127.88 crores by Namita Vikas Thapar, 10,000 equity shares of face value of Rs. 10 each aggregating to Rs. 1.01 crores by Samit Satish Mehta and 40,000 equity shares of face value of Rs. 10 each aggregating to Rs. 4.03 crores by Sunil Rajanikant Mehta (the "Promoter Selling Shareholders"), 7,234,085 equity shares of face value of Rs. 10 each aggregating to Rs. 729.20 crores by BC Investments iv limited (the "Investor Selling Shareholder"), 1,342,586 equity shares of face value of Rs. 10 each aggregating to Rs. 135.33 crores by the promoter group selling shareholders as set out under annexure a (the "Promoter Group Selling Shareholders"), 300,000 equity shares of face value of Rs. 10 each aggregating to Rs. 30.24 crores by Arunkumar Purshotamlal Khanna (the "Individual Selling Shareholder"), and 813,568 equity shares of face value of Rs. 10 each aggregating to Rs. 82.01 crores by other selling shareholders as set out under annexure a (the "Other Selling Shareholders", and collectively with the promoter selling shareholders, promoter group selling shareholders, individual selling shareholder and the investor selling shareholder, the "Selling Shareholders", and each individually, as a "Selling Shareholder" and such offer for sale of equity shares of face value of Rs. 10 each by the selling shareholders, the "Offer for sale").
The offer included a reservation of 108,900 equity shares of face value of Rs. 10 each, aggregating to Rs. 10.00 crores^, for subscription by eligible employees (constituting up to 0.06% of the post-offer paid-up equity share capital)(the "Employee Reservation Portion"). The company, in consultation with the book running lead managers, offered a discount of 8.93% to the offer price (equivalent to Rs. 90 per equity share) to eligible employees biddng under the employee reservation portion ("Employee Discount"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". The offer and the net offer constituted 10.25% and 10.19%, respectively, of the post-offer paid-up equity share capital of the company.
Tthe face value of the equity share is Rs. 10 each and the offer price is 100.80 times the face value of equity shares.
^A discount of Rs. 90 per equity share was offered to eligible employees bidding in the employee reservation portion.